Phytosynthesis of Silver Nanoparticles: Characterization, Biocompatibility Studies, and Anticancer Activity

Kiran Jadhav, Sharada Deore, Dinesh Dhamecha, Rajeshwari Hr, Satveer Jagwani, Sunil Jalalpure, Raghvendra Bohara

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Silver nanoparticles (SNPs), owing to their wide range of biomedical applications, have recently attracted remarkable interest for use in cancer nanomedicine. The present research work investigated the anticancer activity of phytosynthesized SNPs against human cancer cell lines. Phytosynthesis of SNPs was achieved by using an aqueous extract of Salacia chinensis (SC) bark as a green source to reduce silver nitrate to silver nanoparticles. Characterization of synthesized nanoparticles demonstrated a UV-visible peak at 443 nm, ζ-potential (zetasizer) of -25.6 ± 0.34 and particle size (transmission electron microscopy analysis) in the range of 40-80 nm, which validates formation of stable silver nanoparticles. The absence of cytotoxicity against normal human fibroblasts and blood erythrocytes confirms the biocompatible nature of green synthesized SNPs. In vitro anticancer assay demonstrated IC50 values of 6.31, 4.002, 5.228, 8.452, 14.37, 7.46, and 6.55 μg/mL against liver (Hep G2), lungs (L-132), pancreas (MIA-Pa-Ca-2), breast (MDA-MB-231), oral (KB cells), prostate (PC-3), and cervical (HeLa) cancer cell lines respectively, which confirms its potent anticancer action. The results of the present study give an experimental proof that the SC mediated green synthesized SNPs could serve as a promising anticancer agent to overcome limitations of existing conventional cancer chemotherapeutics.

Original languageEnglish
Pages (from-to)892-899
Number of pages8
JournalACS Biomaterials Science and Engineering
Volume4
Issue number3
DOIs
Publication statusPublished - 12-03-2018

Fingerprint

Biocompatibility
Silver
Nanoparticles
Salacia
Cells
Medical nanotechnology
Silver Nitrate
Fibroblasts
Cytotoxicity
Liver
Antineoplastic Agents
Nitrates
Assays
Blood
Particle size
Transmission electron microscopy

All Science Journal Classification (ASJC) codes

  • Biomaterials
  • Biomedical Engineering

Cite this

Jadhav, Kiran ; Deore, Sharada ; Dhamecha, Dinesh ; Hr, Rajeshwari ; Jagwani, Satveer ; Jalalpure, Sunil ; Bohara, Raghvendra. / Phytosynthesis of Silver Nanoparticles : Characterization, Biocompatibility Studies, and Anticancer Activity. In: ACS Biomaterials Science and Engineering. 2018 ; Vol. 4, No. 3. pp. 892-899.
@article{9bca349ffce249cb972001553255609d,
title = "Phytosynthesis of Silver Nanoparticles: Characterization, Biocompatibility Studies, and Anticancer Activity",
abstract = "Silver nanoparticles (SNPs), owing to their wide range of biomedical applications, have recently attracted remarkable interest for use in cancer nanomedicine. The present research work investigated the anticancer activity of phytosynthesized SNPs against human cancer cell lines. Phytosynthesis of SNPs was achieved by using an aqueous extract of Salacia chinensis (SC) bark as a green source to reduce silver nitrate to silver nanoparticles. Characterization of synthesized nanoparticles demonstrated a UV-visible peak at 443 nm, ζ-potential (zetasizer) of -25.6 ± 0.34 and particle size (transmission electron microscopy analysis) in the range of 40-80 nm, which validates formation of stable silver nanoparticles. The absence of cytotoxicity against normal human fibroblasts and blood erythrocytes confirms the biocompatible nature of green synthesized SNPs. In vitro anticancer assay demonstrated IC50 values of 6.31, 4.002, 5.228, 8.452, 14.37, 7.46, and 6.55 μg/mL against liver (Hep G2), lungs (L-132), pancreas (MIA-Pa-Ca-2), breast (MDA-MB-231), oral (KB cells), prostate (PC-3), and cervical (HeLa) cancer cell lines respectively, which confirms its potent anticancer action. The results of the present study give an experimental proof that the SC mediated green synthesized SNPs could serve as a promising anticancer agent to overcome limitations of existing conventional cancer chemotherapeutics.",
author = "Kiran Jadhav and Sharada Deore and Dinesh Dhamecha and Rajeshwari Hr and Satveer Jagwani and Sunil Jalalpure and Raghvendra Bohara",
year = "2018",
month = "3",
day = "12",
doi = "10.1021/acsbiomaterials.7b00707",
language = "English",
volume = "4",
pages = "892--899",
journal = "ACS Biomaterials Science and Engineering",
issn = "2373-9878",
publisher = "American Chemical Society",
number = "3",

}

Phytosynthesis of Silver Nanoparticles : Characterization, Biocompatibility Studies, and Anticancer Activity. / Jadhav, Kiran; Deore, Sharada; Dhamecha, Dinesh; Hr, Rajeshwari; Jagwani, Satveer; Jalalpure, Sunil; Bohara, Raghvendra.

In: ACS Biomaterials Science and Engineering, Vol. 4, No. 3, 12.03.2018, p. 892-899.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Phytosynthesis of Silver Nanoparticles

T2 - Characterization, Biocompatibility Studies, and Anticancer Activity

AU - Jadhav, Kiran

AU - Deore, Sharada

AU - Dhamecha, Dinesh

AU - Hr, Rajeshwari

AU - Jagwani, Satveer

AU - Jalalpure, Sunil

AU - Bohara, Raghvendra

PY - 2018/3/12

Y1 - 2018/3/12

N2 - Silver nanoparticles (SNPs), owing to their wide range of biomedical applications, have recently attracted remarkable interest for use in cancer nanomedicine. The present research work investigated the anticancer activity of phytosynthesized SNPs against human cancer cell lines. Phytosynthesis of SNPs was achieved by using an aqueous extract of Salacia chinensis (SC) bark as a green source to reduce silver nitrate to silver nanoparticles. Characterization of synthesized nanoparticles demonstrated a UV-visible peak at 443 nm, ζ-potential (zetasizer) of -25.6 ± 0.34 and particle size (transmission electron microscopy analysis) in the range of 40-80 nm, which validates formation of stable silver nanoparticles. The absence of cytotoxicity against normal human fibroblasts and blood erythrocytes confirms the biocompatible nature of green synthesized SNPs. In vitro anticancer assay demonstrated IC50 values of 6.31, 4.002, 5.228, 8.452, 14.37, 7.46, and 6.55 μg/mL against liver (Hep G2), lungs (L-132), pancreas (MIA-Pa-Ca-2), breast (MDA-MB-231), oral (KB cells), prostate (PC-3), and cervical (HeLa) cancer cell lines respectively, which confirms its potent anticancer action. The results of the present study give an experimental proof that the SC mediated green synthesized SNPs could serve as a promising anticancer agent to overcome limitations of existing conventional cancer chemotherapeutics.

AB - Silver nanoparticles (SNPs), owing to their wide range of biomedical applications, have recently attracted remarkable interest for use in cancer nanomedicine. The present research work investigated the anticancer activity of phytosynthesized SNPs against human cancer cell lines. Phytosynthesis of SNPs was achieved by using an aqueous extract of Salacia chinensis (SC) bark as a green source to reduce silver nitrate to silver nanoparticles. Characterization of synthesized nanoparticles demonstrated a UV-visible peak at 443 nm, ζ-potential (zetasizer) of -25.6 ± 0.34 and particle size (transmission electron microscopy analysis) in the range of 40-80 nm, which validates formation of stable silver nanoparticles. The absence of cytotoxicity against normal human fibroblasts and blood erythrocytes confirms the biocompatible nature of green synthesized SNPs. In vitro anticancer assay demonstrated IC50 values of 6.31, 4.002, 5.228, 8.452, 14.37, 7.46, and 6.55 μg/mL against liver (Hep G2), lungs (L-132), pancreas (MIA-Pa-Ca-2), breast (MDA-MB-231), oral (KB cells), prostate (PC-3), and cervical (HeLa) cancer cell lines respectively, which confirms its potent anticancer action. The results of the present study give an experimental proof that the SC mediated green synthesized SNPs could serve as a promising anticancer agent to overcome limitations of existing conventional cancer chemotherapeutics.

UR - http://www.scopus.com/inward/record.url?scp=85043595261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043595261&partnerID=8YFLogxK

U2 - 10.1021/acsbiomaterials.7b00707

DO - 10.1021/acsbiomaterials.7b00707

M3 - Article

AN - SCOPUS:85043595261

VL - 4

SP - 892

EP - 899

JO - ACS Biomaterials Science and Engineering

JF - ACS Biomaterials Science and Engineering

SN - 2373-9878

IS - 3

ER -